Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Myers Industries Announces 2026 Third Quarter Results
-
TPG Reports Third Quarter 2026 Results
-
Upbound Group, Inc. Reports Third Quarter 2026 Results
-
Tradeweb Reports Third Quarter 2026 Financial Results
-
T. ROWE PRICE GROUP REPORTS THIRD QUARTER 2026 RESULTS
-
Quantum XChange Warns AI Systems Face Growing Quantum Security Threat as Adversaries Harvest Encrypted Data
-
CRITEO APPOINTS JIANCHANG "JC" MAO TO ITS BOARD OF DIRECTORS
-
LiveWire Group, Inc. Reports 2026 Third Quarter Financial Results
-
Bandwidth Announces Third Quarter 2026 Financial Results
-
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
-
Angel Announces “The Angel Promise,” Deepening Commitment to Values-Driven Entertainment
-
Certified-PEP Publishes 2026 Research Peptide Supplier Comparison
-
Blackstone Mortgage Trust Reports Third-Quarter 2026 Results
-
Dream Finders Homes Announces Third Quarter 2026 Results
-
Frontier Medicines Announces FDA Allowance to Proceed Under an IND for FMC-242, a Novel Covalent Allosteric PI3Kα-RAS Breaker, in Patients with Select Advanced Solid Tumors
-
Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer
-
Stratasys Conference Call to Discuss Third Quarter 2026 Financial Results
-
A2Z Cust2Mate Announces Timing of Third Quarter 2026 Earnings Release and Conference Call
-
Cognitive Credit Launches DealConnect: The Complete Workflow Solution for Restricted Deal Credit Analysis
-
Open Enrollment Is Here: What New Mexicans Should Know When Choosing 2027 Health Coverage
-
UNIFI®, Makers of REPREVE®, Completes Sale of Non-Strategic U.S. Real Estate for Gross Proceeds of $60 Million
-
Brixton Biosciences Announces Pivotal Clinical Data for Reneurx™ Nerve-Selective Therapy in Knee Osteoarthritis to be Presented at AAHKS 2026
-
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
-
Advisory List Examines Who Is Buying Accounting Firms and What It Means for Owners
-
Base.com Recognized in the 2026 Gartner® Magic Quadrant™ for Product Information Management Solutions
-
TelevisaUnivision Announces Third Quarter 2026 Results
-
New Jersey Resources Schedules Fiscal 2026 Fourth Quarter and Year-End Earnings Call
-
Bites Raises $40M Series A to Turn Frontline Training into a Business Performance Engine
-
Open Enrollment Is Here: What Texans Should Know When Choosing 2027 Health Coverage
-
RedBird Capital Partners and Guy Oseary’s Sound Ventures Announce $1 Billion Strategic Partnership
-
Bausch + Lomb Announces Publication of Multinational Survey Results Highlighting the Burden of Dry Eye Symptoms and Opportunities for Improved Awareness and Patient Education
-
Sound Point Meridian Capital, Inc. Schedules Second Fiscal Quarter Ended September 30, 2026 Earnings Release and Conference Call
-
Cosm Medical Achieves Reimbursement Pathway Milestone: US CPT® Codes Recognize the Work Behind Personalized Pessaries
-
Aircall Co-Founder Olivier Pailhès Returns as CEO
-
National Vision Holdings, Inc. Announces Third Quarter 2026 Earnings Release and Conference Call
-
Valvoline Inc. to Report Financial Results for Fourth Quarter 2026 and Host Webcast on November 19
-
Tilray Brands Announces Next Phase of Beverage Transformation
-
Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance
-
Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)
-
Open Enrollment Is Here: What Illinoisans Should Know When Choosing 2027 Health Coverage
-
Amplify ETFs Declares October Income Distributions for its Income ETFs
-
Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
-
Verano Announces Strong Third Quarter 2026 Financial Results Highlighted by $212 Million in Revenue and Year-Over-Year Organic Growth
-
WSP selected as strategic delivery partner for American Electric Power
-
Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London
-
Matternet Partners with Swisslog Healthcare's TransLogic to Bring Drone Delivery to Thousands of North American Hospitals
-
Flux Power Advances Battery Safety and Fleet Intelligence with Three New Innovations
-
HII Reports Third Quarter 2026 Results
